Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
A Full-Service Solution Partner Disrupting the Outsourcing Paradigm inSeption Group offers a full-service solution designed to disrupt the current outsourcing paradigm, resurrecting a common-sense approach to rebuild business trust and confidence in a client’s selected vendor.
The biopharmaceutical market within the Japan and Asia-Pacific (JAPAC) region has grown consistently since 2010, specifically for emerging biopharmas (EBPs). In fact, in 2018, 80% of all biopharma pipeline projects in JAPAC were EBPs, accounting for 75% of the total clinical trial volume in the region.
Globally, the pursuit for treatments with better patient outcomes and more effective care is a never-ending quest. As diseases and viruses evolve, the research and development of new medicines and treatments has also grown rapidly. Around the world, the global funding of Emerging Biopharmaceutical companies (EBPs) has grown rapidly, from $18 billion in 2010 to over $130 billion in 2020, with a compound annual growth rate of over 20%.
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
